vTv Therapeutics (VTVT) Return on Sales Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.00 |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | 1,191.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,191.00 |
| Sep 30, 2025 | -1,655.00 |
| Jun 30, 2025 | -950.00 |
| Mar 31, 2025 | -1,343.00 |
| Dec 31, 2024 | 793.00 |
| Sep 30, 2024 | -22.00 |
| Jun 30, 2024 | 68.00 |
| Mar 31, 2024 | 0.00 |
| Sep 30, 2023 | -2,746.00 |
| Jun 30, 2023 | -1,640.00 |
| Mar 31, 2023 | -295.00 |
| Dec 31, 2022 | 306.00 |
| Sep 30, 2022 | 731.00 |
| Jun 30, 2022 | -452.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -1,053.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -90.00 |
| Mar 31, 2021 | -1.00 |
| Dec 31, 2020 | 63.00 |
| Sep 30, 2020 | 502.00 |
| Jun 30, 2020 | -55.00 |
| Mar 31, 2020 | -419.00 |
| Dec 31, 2019 | -622.00 |
| Sep 30, 2019 | -390.00 |
| Jun 30, 2019 | 78.00 |
| Mar 31, 2019 | 32.00 |
| Dec 31, 2018 | 48.00 |
| Sep 30, 2018 | 73.00 |
| Jun 30, 2018 | 91.00 |
| Mar 31, 2018 | 191.00 |
| Dec 31, 2017 | -54.00 |
| Sep 30, 2017 | -809.00 |
| Jun 30, 2017 | -996.00 |